Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.

Phosphorylation of the microtubule-associated Tau protein plays a major role in the regulation of its activity of tubulin polymerization and/or stabilization of microtubule assembly. A dysregulation of the phosphorylation/dephosphorylation balance leading to the hyperphosphorylation of Tau proteins in neurons is thought to favor their aggregation into insoluble filaments. This in turn might underlie neuronal death as encountered in many neurodegenerative disorders, including Alzheimer's disease. Another post-translational modification, the O-linked β-N-acetylglucosaminylation (O-GlcNAcylation), controls the phosphorylation state of Tau, although the precise mechanism is not known. Moreover, analytical difficulties have hampered the precise localization of the O-GlcNAc sites on Tau, except for the S400 site that was very recently identified on the basis of ETD-FT-MS. Here, we identify three O-GlcNAc sites by screening a library of small peptides sampling the proline-rich, the microtubule-associated repeats and the carboxy-terminal domains of Tau as potential substrates for the O-β-N-acetylglucosaminyltransferase (OGT). The in vitro activity of the nucleocytoplasmic OGT was assessed by tandem mass spectrometry and NMR spectroscopy. Using phosphorylated peptides, we establish the relationship between phosphate and O-GlcNAc incorporation at these sites. Phosphorylation of neighboring residues S396 and S404 was found to decrease significantly S400 O-GlcNAcylation. Reciprocally, S400 O-GlcNAcylation reduces S404 phosphorylation by the CDK2/cyclinA3 kinase and interrupts the GSK3β-mediated sequential phosphorylation process.

[1]  I. Landrieu,et al.  Spectroscopic Studies of GSK3β Phosphorylation of the Neuronal Tau Protein and Its Interaction with the N-terminal Domain of Apolipoprotein E , 2010, The Journal of Biological Chemistry.

[2]  L. Buée,et al.  NMR spectroscopy of the neuronal tau protein: normal function and implication in Alzheimer's disease. , 2010, Biochemical Society transactions.

[3]  G. Davies,et al.  Structural analyses of enzymes involved in the O-GlcNAc modification. , 2010, Biochimica et biophysica acta.

[4]  J. Shabanowitz,et al.  Enrichment and Site Mapping of O-Linked N-Acetylglucosamine by a Combination of Chemical/Enzymatic Tagging, Photochemical Cleavage, and Electron Transfer Dissociation Mass Spectrometry* , 2009, Molecular & Cellular Proteomics.

[5]  Jianhua Shi,et al.  Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease. , 2009, Brain : a journal of neurology.

[6]  I. Landrieu,et al.  Alzheimer disease specific phosphoepitopes of Tau interfere with assembly of tubulin but not binding to microtubules , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  S. Shenolikar,et al.  From promiscuity to precision: protein phosphatases get a makeover. , 2009, Molecular cell.

[8]  D. Schwarzer,et al.  Chemoselective ligation and modification strategies for peptides and proteins. , 2008, Angewandte Chemie.

[9]  G. Hart,et al.  O-Linked β-N-Acetylglucosaminyltransferase Substrate Specificity Is Regulated by Myosin Phosphatase Targeting and Other Interacting Proteins* , 2008, Journal of Biological Chemistry.

[10]  Yigong Shi,et al.  Structure of a protein phosphatase 2A holoenzyme: insights into B55-mediated Tau dephosphorylation. , 2008, Molecular cell.

[11]  A. W. Schüttelkopf,et al.  Structural insights into mechanism and specificity of O-GlcNAc transferase , 2008, The EMBO journal.

[12]  P. Fischer Turning down tau phosphorylation. , 2008, Nature chemical biology.

[13]  G. Davies,et al.  Structure of an O-GlcNAc transferase homolog provides insight into intracellular glycosylation , 2008, Nature Structural &Molecular Biology.

[14]  G. Davies,et al.  A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. , 2008, Nature chemical biology.

[15]  I. Landrieu,et al.  Microinjection of recombinant O-GlcNAc transferase potentiates Xenopus oocytes M-phase entry. , 2008, Biochemical and biophysical research communications.

[16]  V. Janssens,et al.  PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). , 2008, Trends in biochemical sciences.

[17]  Linda C Hsieh-Wilson,et al.  Chemical approaches to understanding O-GlcNAc glycosylation in the brain. , 2008, Nature chemical biology.

[18]  I. Grundke‐Iqbal,et al.  Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease , 2008, FEBS letters.

[19]  Scott B Ficarro,et al.  Probing the dynamics of O-GlcNAc glycosylation in the brain using quantitative proteomics. , 2007, Nature chemical biology.

[20]  Gerald W. Hart,et al.  Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins , 2007, Nature.

[21]  Barry M Wise,et al.  Prediction of nucleating sequences from amyloidogenic propensities of tau-related peptides. , 2006, Biochemistry.

[22]  H. Paudel,et al.  Cyclin-dependent protein kinase 5 primes microtubule-associated protein tau site-specifically for glycogen synthase kinase 3beta. , 2006, Biochemistry.

[23]  K. Saxena,et al.  NMR Analysis of a Tau Phosphorylation Pattern , 2006 .

[24]  H. Paudel,et al.  Glycogen synthase kinase 3beta phosphorylates Alzheimer's disease-specific Ser396 of microtubule-associated protein tau by a sequential mechanism. , 2006, Biochemistry.

[25]  S. Walker,et al.  Discovery of O-GlcNAc transferase inhibitors. , 2005, Journal of the American Chemical Society.

[26]  L. Buée,et al.  Regulation of Pin1 peptidyl‐prolyl cis/trans isomerase activity by its WW binding module on a multi‐phosphorylated peptide of Tau protein , 2005, FEBS letters.

[27]  K. Kosik,et al.  Phosphorylated tau and the neurodegenerative foldopathies. , 2005, Biochimica et biophysica acta.

[28]  G. Johnson,et al.  Tau phosphorylation: physiological and pathological consequences. , 2005, Biochimica et biophysica acta.

[29]  A. Delacourte,et al.  Tau protein as a differential biomarker of tauopathies. , 2005, Biochimica et biophysica acta.

[30]  I. Landrieu,et al.  Accepting its Random Coil Nature Allows a Partial NMR Assignment of the Neuronal Tau Protein , 2004, Chembiochem : a European journal of chemical biology.

[31]  M. Jinek,et al.  The superhelical TPR-repeat domain of O-linked GlcNAc transferase exhibits structural similarities to importin α , 2004, Nature Structural &Molecular Biology.

[32]  G. Hart,et al.  O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[33]  D. Kirschner,et al.  The Formation of Straight and Twisted Filaments from Short Tau Peptides* , 2004, Journal of Biological Chemistry.

[34]  A. Delacourte,et al.  Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization. , 2003, Biochimica et biophysica acta.

[35]  J. Hanover,et al.  Mitochondrial and nucleocytoplasmic isoforms of O-linked GlcNAc transferase encoded by a single mammalian gene. , 2003, Archives of biochemistry and biophysics.

[36]  N. Leymarie,et al.  Tandem mass spectrometry for structural characterization of proline-rich proteins: application to salivary PRP-3. , 2002, Analytical chemistry.

[37]  G. Hart,et al.  Dynamic O-Glycosylation of Nuclear and Cytosolic Proteins , 2001, The Journal of Biological Chemistry.

[38]  V. Janssens,et al.  Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. , 2001, The Biochemical journal.

[39]  René Hen,et al.  Decreased nuclear β‐catenin, tau hyperphosphorylation and neurodegeneration in GSK‐3β conditional transgenic mice , 2001 .

[40]  M. Mercken,et al.  Glycogen Synthase Kinase-3β Phosphorylates Protein Tau and Rescues the Axonopathy in the Central Nervous System of Human Four-repeat Tau Transgenic Mice* , 2000, The Journal of Biological Chemistry.

[41]  D. Craik,et al.  Role of phosphorylation in the conformation of tau peptides implicated in Alzheimer's disease. , 2000, Biochemistry.

[42]  L. Johnson,et al.  The structural basis for specificity of substrate and recruitment peptides for cyclin-dependent kinases , 1999, Nature Cell Biology.

[43]  U. Wagner,et al.  Tau phosphorylation in transgenic mice expressing glycogen synthase kinase‐3β transgenes , 1997, Neuroreport.

[44]  G. Hart,et al.  The Microtubule-associated Protein Tau Is Extensively Modified with O-linked N-acetylglucosamine* , 1996, The Journal of Biological Chemistry.

[45]  R. Crowther,et al.  Comparison of the neurofibrillary pathology in Alzheimer’s disease and familial presenile dementia with tangles , 1996, Acta Neuropathologica.

[46]  M. Goedert,et al.  Protein Phosphatase 2A Is the Major Enzyme in Brain that Dephosphorylates τ Protein Phosphorylated by Proline‐Directed Protein Kinases or Cyclic AMP‐Dependent Protein Kinase , 1995 .

[47]  K. Titani,et al.  Hyperphosphorylation of Tau in PHF , 1995, Neurobiology of Aging.

[48]  E. Vanmechelen,et al.  Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205 , 1995, Neuroscience Letters.

[49]  K. Titani,et al.  Proline-directed and Non-proline-directed Phosphorylation of PHF-tau (*) , 1995, The Journal of Biological Chemistry.

[50]  Simon Lovestone,et al.  Alzheimer's disease-like phosphorylation of the microtubule-associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells , 1994, Current Biology.

[51]  I. Grundke‐Iqbal,et al.  Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A , 1994, Neuroscience.

[52]  P. Cohen,et al.  Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein. , 1994, The Biochemical journal.

[53]  E. Mandelkow,et al.  Dephosphorylation of tau protein and Alzheimer paired helical filaments by calcmeurin and phosphatase‐2A , 1993, FEBS letters.

[54]  J. Woodgett,et al.  Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase , 1992, Neuroscience Letters.